Interieukin-4 receptor expression in vivo on human aids-related kaposi's sarcoma

Oncology Research

Volumn 9, Issue 9, 1997, Pages 495-503

  Varricchio, Frederick ^a   Rafat Husain, S ^a   Leland, Pamela ^b   Gill, Parkash ^b   Puri, Raj K ^b  

^a Vaccine Safety Branch   (United States)

^b Division of Cellular and Gene Therapies   (United States)

Author keywords

Basic fibroblast growth factor; s 100; Immunohistochemistry; Interleukin 4 receptors; Kaposi's sarcoma

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; MESSENGER RNA; MONOCLONAL ANTIBODY; TUMOR PROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CELL CULTURE; FLOW CYTOMETRY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; KAPOSI SARCOMA; METABOLISM; PATHOLOGY; SKIN; SKIN TUMOR; UPREGULATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ANTIBODIES, MONOCLONAL; FIBROBLAST GROWTH FACTOR 2; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; INTERCELLULAR ADHESION MOLECULE-1; INTERLEUKIN-4; NEOPLASM PROTEINS; RECEPTORS, INTERLEUKIN-4; RNA, MESSENGER; SARCOMA, KAPOSI; SKIN; SKIN NEOPLASMS; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0031307436     PISSN: 09650407     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Safai, B.; Johnson, K. G.; Myskowski, P. L.; Koziner, B.; Yang, S. Y.; Cunningham-Rundles, S.; Goodbold, J. H.; Dupont, B. The natural history of Kaposi's sarcoma in the acquired immune deficiency syndrome. Ann. Int. Med. 103:744-750; 1985.
2. Cockrell, C. J. Histopathological features of Kaposi's sarcoma in H1V infected individuals. Cancer Surv. 10:73-89; 1991.
3. Roth, W. K.; Werner, S.; Risau, W.; Remberger, K.; Hofschneider, P. H. Cultured, AIDS-related Kaposi's sarcoma cells express endothelial cell markers and are weakly malignant in vitro. Int. J. Cancer 42:767-773; 1988.
4. Kraffert, C.; Planus, L.; Penneys, N. S. Kaposi's sarcoma: Further immunohistologic evidence of a vascular endothelial origin. Arch. Dermatol. 127:1734-1735; 1991.
5. Rutgers, J. L.; Wieczorek, R.; Bonetti, F.; Kaplan, K. L.; Posnett, D. N.; Friedman-Kien, A. E.; Knowles, D. M., II. The expression of endothelial cell surface antigens by AIDS-associated Kaposi's sarcoma. Am. J. Pathol. 122:493-499; 1986.
6. Weich, H. A.; Salahuddin, S. Z.; Gill, P.; Nakamura, S.; Gallo, R. C.; Folkman, J. AIDS-associated Kaposi's sarcomaderived cells in long term culture express and synthesize smooth muscle a-actin. Am. J. Pathol. 139:1251-1258; 1991.
7. Huang, Y. Q.; Friedman-Kien, A. E.; Li, J.; Nickoloff, B. J. Cultured Kaposi's sarcoma cell lines express factor XHIa, CD14, and VCAM-1, but not factor VIII or ELAM-1. Arch. Dermatol. 129:1291-1296; 1993.
8. Nickoloff, B. J.; Griffiths, C. E. M. The spindle-shaped cells in cutaneous Kaposi's sarcoma. Am. J. Pathol. 125:793-800; 1989.
9. Nickoloff, B. J.; Griffiths, C. E. M. Factor Xllla-expressing dermal dendrocytes in AIDS-associated cutaneous Kaposi's sarcoma. Science 243:1736-1737; 1989.
10. Shmueli, D.; Sghapira, Z.; Yussin, A.; Nakache, R.; Ram, Z.; Shaharbani, E. The incidence of Kaposi's sarcoma in renal transplant patients and its relation to immunosuppression. Transplant Proc. 21:3209-3210; 1989.
11. Haverkos, H.; Drotman, D.; Morgan, M. Prevelance of Kaposi's sarcoma among patients with AIDS [letter]. N. Engl. J. Med. 312:1518; 1985.
12. Ensoli, B.; Salahuddin, S. Z.; Gallo, R. C. AIDS-associated Kaposi's sarcoma: A molecular model for its pathogenesis. Cancer Cells 1:93-96; 1989.
13. Ensoli, B.; Barillari, G.; Buonaguro, L.; Gallo, R. C. Molecular mechanisms in the pathogenesis of AIDS-associated Kaposi's sarcoma. Adv. Exp. Med. Biol. 303:27-38; 1991.
14. Ensoli, B.; Barillari, G.; Gallo, R. C. Pathogenesis of AIDSassociated Kaposi's sarcoma. Hermatol. Oncol. Clin. North Am. 5:281-295; 1991.
15. de Wit, R.; Raasveld, M. H. M.; ten Berge, R. J. M.; van der Wouw, P. A.; Bakker, P. J. M.; Veenhof, C. H. N Interleukin-6 concentrations in the serum of patients with AIDSassociated Kaposi's sarcoma during treatment with interferonalpha. J. Intern. Med. 229:539-542; 1991.
16. Miles, S. A.; Rezai, A. R.; Salazar, G. J. F.; Vander, M. M.; Stevens, R. H.; Logan, D. M.; Mitsuyasu, R. T.; Taga, T.; Hirano, T.; Kishimoto, T.; Mertinez-Maza, O. AIDSKaposi's sarcoma-derived cells produce and respond to interleukin-6. Proc. Natl. Acad. Sei. USA 87:4068-4072; 1990.
17. Ensoli, B.; Nakamura, S.; Salahuddin, S. Z.; Biberfeld, P.; Larsson, L.; Beaver, B.; Wong-Staal, F.; Gallo, R. C. AIDSKaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 243:223-226; 1989.
18. Miles, S. A.; Rezai, A.; Salazar, G. J. F.; Vander, M. M.; Steven, R. H.; Logan, D. M.; Mertinez, M. O.; Magpantay, L.; Kishimoto, K.; Nakamura, S.; Radka, S. F.; Linsley, P. S. Oncostatin M as a potent mitogen for AIDS-Kaposi's sarcoma-derived cells. Science 255:1432-1434; 1992.
19. Nakamura, S.; Salahuddin, S. Z.; Biberfield, P.; Ensoli, B.; Markham, P. D.; Wong-Staal, F.; Gallo, R. C. Kaposi's sarcoma cells: Long term culture with growth factor from retrovirus-infected CD4+ T cells. Science 242:426-430; 1988.
20. Oxholm, A.; Oxholm, P.; Permin, H.; Bendzen, K. Epidermal tumor necrosis factor alpha and interleukin-6 like activities in AIDS-related Kaposi's sarcoma: An immunological study. APMIS 97:533-5381 1989.
21. Xerri, L.; Hassoun, J.; Planche, J.; Guigon, V.; Grob, J.-J.; Pare, P.; Birnbaum, D.; deLapeyriere, O. Fibroblast growth factor gene expression in AIDS-Kaposi's sarcoma detected by in situ hybridization. Am. J. Pathol. 138:9-15; 1991.
22. Werner, S.; Hofschneider, P. H.; Heldin, C.-H.; Ostman, A.; Roth, W. K. Cultured Kaposi's sarcoma-derived cells express functional PDGF A-type and B-type receptors. Exp. Cell Res. 187:98-103; 1990.
23. Werner, S.; Hofschneider, P. H.; Sturzl, M.; Dick, L; Roth, W. K. Cytochemical and molecular properties of simian virus 40 transformed fibroblast growth factor family. J. Cell. Physiol. 141:490-502; 1989.
24. Sturzl, M.; Roth, W. K.; Brockmeyer, N. H.; Zietz, C.; Speiser, B.; Hofschneider, P. H. Expression of plateletderived growth factor and its receptor in AIDS-related Kaposi's sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance. Proc. Natl. Acad. Sei. USA 89:7046-7050; 1992.
25. Masood, R.; Lunardi-Iskandar, Y.; Lee Fong, L. J.; Murphy,J. R.; Waters, C.; Gallo, R. C.; Gill, P. S. Inhibition of AlDS-associated Kaposi's sarcoma cell growth by DAB389interleukin-6. AIDS Res. Hum. Retrovirus 10:969-975; 1994.
26. Ensoli, B.; Barillari, G.; Salahuddin, S. Z.; Gallo, R. C.; Wong-Staal, F. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345:84-86; 1990.
27. Ensoli, B.; Buonaguro, L.; Barillari, G.; Fiorelli, V.; Gendelman, R.; Morgan, R. A.; Wingfield, P.; Gallo, R. C. Release, uptake and effects of extracellular human immunodeficiency virus type I Tat protein on cell growth and viral transactivation. J. Virol. 67:277-287; 1993.
28. Barillari, G.; Buonaguro, L.; Fiorelli, V.; Huffman, J.; Michaels, F.; Gallo, R. C.; Ensoli, B. Effects of cytokines from activated immune cell on vascular cell growth and HIV-1 gene expression. Implications for AIDS-Kaposi's sarcoma pathogenesis. J. Immunol. 149:3727-3734; 1992.
29. Barillari, G..; Gendelman, R.; Gallo, R. C.; Ensoli, B. The Tat protein of human immunodeficiency virus type 1, a growth factor AIDS Kaposi's sacrcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizing the ROD amino acid sequence. Proc. Natl. Acad. Sei. USA 90:7941-7945; 1993.
30. Albini, A.; Barillari, G.; Benelli, R.; Gallo, R. C.; Ensoli, B. Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc. Natl. Acad. Sei. USA 92:4838-4842; 1995.
31. Ensoli, B.; Gendelman, R.; Markham, P.; Fiorelli, V.; Colombini, S.; Raffeld, M.; Cafaro, A.; Chang, H-K.; Brady, J. N.; Gallo, R. C. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma. Nature 371:674-680; 1994.
32. Puri, R. K.; Siegel, J. P. Interleukin-4 and cancer therapy. Cancer Invest. 11:479-486; 1993.
33. Puri, R. K. Structure and functions of interleukin 4 and its receptor. In: Kurzock, R.; Talpaz, M., eds. Cytokines: Interleukins and their receptors. Norwell, MA: Kluwer Academic Publishers; 1995:143-185.
34. Obiri, N. I.; Hillman, G. G.; Haas, G. P.; Sudha, S.; Puri, R. K. Expression of high affinity IL-4 receptors on human renal cell carcinoma cells and inhibition of tumor cell growth in vitro by IL-4. J. Clin. Invest. 91:88-93; 1993.
35. Obiri, N. I.; Siegel, J. P.; Varricchio, F.; Puri, R. K. Expression and function of high affinity interleukin-4 receptors on human melanoma, ovarian and breast carcinoma cells. Clin. Exp. Immunol. 95:148-155; 1994.
36. Varricchio, F.; Obiri, N. I.; Haas, G. P.; Puri, R. K. Immunostaining of interleukin-4 receptor on human renal cell carcinoma. Lymphokine Cytokine Res. 12:465-469; 1993.
37. Husain, S. R.; Gill, P.; Kreitman, R. J.; Pastan, I.; Puri, R. K. Interleukin-4 receptor expression on AIDS-associated Kaposi's sarcoma cells and their targeting by a chimeric protein comprised of circularly permuted interleukin-4 and Pseudomonasexotoxin. Mol. Med. 3:327-338; 1997.
38. Lunardi-Iskandar, Y.; Bryant, J. L.; Zeman, R. a.; Lam, V. H.; Samaniego, F.; Besnier, J. M.; Hermans, P.; Thierry, A. R.; Gill, P.; Gallo, R. C. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by human pregnancy hormone. Nature 375:64-68; 1995.
39. Fanslow. W. C.; Spriggs, M. K.; Rauch, C. T.; Clifford, K. N.; Macduff, B. M.; Ziegler, S. F.; Schooley, K. A.; Mohler, K. M.; March, C. J.; Armitage, R. J. Identification of a distinct low affinity receptor for human interleukin-4 on pre-B cells. Blood 81:2998-3005; 1993.
40. Niedt, G. W.; Myskowski, P. L.; Urmacher, C.; Niedzwiecki, D.; Chapman, D.; Safai, B. Histology of early lesions of AIDS-associated Kaposi's sarcoma. Mod. Pathol. 3:644-670; 1990.
41. Schwartz, J. L.; Muhlbauer, J. E.; Steigbigel, R. T. PreKaposi's sarcoma. J. Am. Acad. Dermatol. 11:377; 1987.
42. Ruszczak, Z.; Mayer-Da Silva, A.; Orfanos, C. E. Kaposi's sarcoma in AIDS. Multicentric angioneoplasia in early lesions. Am. J. Dermatopathol. 9:388-398; 1987.
43. Niedt, G. W.; Myskowski, P. L.; Urmacher, C.; Niedzwiecki, D.; Chapman, D.; Krown, S. E.; Safai, B. Histologie predictors of survival in aquired immunodeficiency syndromeassociated Kaposi's sarcoma. Hum. Pathol. 23:1419-1426; 1992.
44. Roth, W. K.; Brandstetter, H.; Sturzl, M. Cellular and molecular features of HIV-associated Kaposi's sarcoma. AIDS 6: 895-913; 1992.
45. Massarelli, G.; Scott, C. A.; Ibba, M.; Tanda, F.; Cossu, A. Immunocytochemical profile of Kaposi's sarcoma cells: Their reactivity to a panel of antibodies directed against different tissue cell markers. Appl. Pathol. 7:34-41; 1989.
46. Obiri, N. 1.; Tandon, N.; Puri, R. K. Upregulation of intercellular adhesion molecule-l on human renal cell carcinoma cells byinterleukin-4. Int. J. Cancer 61: 635-642; 1995.
47. Dustin, M. L.; Rothlein, R.; Bhan, A. K.; Dinarello, C. A.; Springier, T. A. Induction of IL-1 and Interferon-?: Tissue distribution, biochemistry and function of a natural adherence molecule (ICAM-1). J. Immunol. 137:245-254; 1986.
48. Valent, P.; Majdic, O.; Bettelheim, P. In: Knapp, W., ed. Leukocyte typing IV. Oxford: Oxford University Press; 1991: 913-914.
49. Holzmann, B.; Johnson, J. P.; Kaudewitz, P.; Riethmuller, G. In situ analysis of antigens on malignant and benign cells of the melanocytes lineage: Differential expression of 2 surface molecules, gp 75 and gp 89. J. Exp. Med. 161:366-377; 1985.
50. Holzmann, B.; Broker, E. B.; Lehmann, J. M.; Ruiter, D. J.; Sorg, C.; Riethmuller, G.; Johnson, J. P. Tumor progression in human malignant melanoma: Five stages defined by their antigenic phenotypes. Int. J. Cancer 39:466-471; 1987.
51. Dustin, M. L.; Springer, T. A. Lymphocyte function associated antigen-1 (LFA-1) interaction with intercellular adhesion molecue-1 (ICAM-I) is one of at least three mechanisms for lymphocyte adhesion to cultured endothelial cells. J. Cell. Biol. 107:321-331; 1988.
52. Butcher, E. C. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 67:1033-1036; 1991.
53. Sanchez-Madrid, F.; Krensky, A. M.; Ware, C. F.; Robbins, E.; Strominger, J. L.; Burakoff, S. J.; Springer, T. A. Three distinct antigens associated with human T lymphocytemediated cytolysis: LFA-1, LFA-2, LFA-3. Proc. Natl. Acad. Sei. USA 79:7489; 1992.
54. Shimizu, Y.; Van Seventer, G. A.; Horgan, K. J.; Shaw, S. Roles of adhesion molecules in T-cell recognition: Fundamental similarities between four integrins on resting human T cells (LFA-1, VLA-4, VLA-5, VLA-6) in expression, binding and costimulation. Immunol. Rev. 114:109; 1990.
55. Roberson, M. J.; Caligiuri, M. A.; Manley, T. J.; Levine, H.; Ritz, J. Human natural killer cell adhesion molecules. Differential expression after activation and participation in cytolysis. J. Immunol. 145:3194; 1990.
56. Puri, R. K.; Aggarwal, B. B. HIV-1 tat gene upregulates IL-4 receptors on a human B-lymphoblastoid cell line. Cancer Res. 52:3783-3790; 1992.
57. Fisher, A. G.; Feinberg, M. B.; Josephs, S. F.; Harper, M. E.; Marselle, L. M.; Reyes, G.; Gonda, M. A.; Aldovini, A.; Debouk, C.; Gallo, R. C.; Wong-Staal, F. The trans-activator gene of HTLV-III is essential for virus replication. Nature 320:367-371; 1986.
58. Vogel, J.; Hinrichs, S. H.; Reyolds, R. K.; Luciw. P. A.; Jay, J. The HIV tat gene induces dermal lesions resembling Kaposi's sarcoma in transgenic mice. Nature 335:606-611; 1988.
59. Puri, R. K.; Debinski, W.; Obiri, N.; Kreitman, R.; Pastan, I. Human renal cell carcinoma cells are sensitive to the cytotoxic effect of a chimeric protein comprised of human interIeukin-4 and Pseudomonas exotoxin. Cell. Immunol. 154:369-379; 1994.
60. Debinski, W.; Puri, R. K.; Pastan, I. Chimeric toxin composed of human interleukin 4 and derivatives of Pseudonwnas exotoxin A are potent antitumor agents in mice. Int. J. Cancer 58:744-748; 1994.
61. Kreitman, R. J.; Puri, R. K.; Pastan, I. A circularly permutated recombinant interleukin-4 toxin with increased activity. Proc. Nail. Acad. Sei. USA 91:6889-6893; 1994.
62. Puri, R. K.; Leland, P.; Kreitman, R. J.; Pastan, 1. Human neurological cancer cells express interleukin-4 (1L-4) receptors which are targets for the cytotoxic effect of lL4-Pseudomonas exotoxin chimeric protein. Int. J. Cancer 58:574-581; 1994.
63. Puri, R. K.; Leland, P.; Obiri, N. I.; Husain, S. R.; Mule, J.; Pastan, I.; Kreitman, R. J. An improved circularly permutated interleukin 4-toxin is highly cytotoxic 10 human renal cell carcinoma cells: Introduction of 7C chain in RCC cells does not improve sensitivity. Cell. Immunol. 171:80-86; 1996.